Kexing Biopharm (688136.SH) announced that as of July 30, 2024, the shareholding entity has accumulated 980,119 shares of the company through the Shanghai Stock Exchange trading system through centralized bidding, accounting for 0.49% of the total share capital of the company. The total amount of shareholding is RMB 13.0885 million, which has exceeded the minimum amount of this shareholding plan. The shareholding plan has expired and has been fully implemented.
Shareholding entities: Mr. Deng Xueqin, the actual controller and chairman of the company, Mr. Zhao Yanqing, director and general manager, Ms. Wang Xiaoqin, director, board secretary and CFO, Ms. Cui Ning, director and deputy general manager, and Mr. Shao Ke and Ms. Ma Hongjie, deputy general managers.